⚡We're live in 30 mins with the Impact on Blood Cancer event! Join us to find out how IHI and IMI projects are using #BigData, #RealWorldData and #CAR-T cell technology to improve outcomes for patients with #BloodCancer! link.europa.eu/hdYgBh
📢 It's the last day of #WorldBloodCancerAwarenessMonth!
⚡Join us tomorrow, Oct 1 at 10:30 CET for our Impact on Blood Cancer event & find out how our projects are leveraging #RealWorldData #BigData to improve patient outcomes & improving #CARTCell capabilities.
👉 REGISTER HERE: https://link.europa.eu/hdYgBh
📊 Want to turn data into powerful decisions?
Upskill with Royed’s Real-World Evidence (RWE) Online Certification!
Gain practical, new edged skills .
🔗 https://zurl.co/aPCdf
#RWE #PharmaCareers #RoyedTraining #Upskill #RealWorldData #Pharma
#ActivityRecognition #research: I am looking for an outlet (peer reviewed) for a #tutorial paper on collecting #multimodal #data with #wearables and #IoT in #nursing homes. We learnt a lot in our pilot study in a #dementia #care ward and want to share our insights/mistakes with a broader audience (#Nursing, #Physiotherapy, #Psychology, #Neurology, #Gerontology) Anyone with a tip for an outlet that accepts a collection of practical considerations for collecting #realWorldData?
#BfArM-Chef über Pläne für Forschungsdateninfrastruktur, #RealWorldData und mehr. Bald sollen verschiedene Daten gesetzlich Versicherter zu Forschungszwecken zur Verfügung stehen. Das BfArM freut sich und baut dafür die Infrastruktur auf. https://www.heise.de/news/BfArM-Chef-ueber-Plaene-fuer-Forschungsdateninfrastruktur-Real-World-Data-und-mehr-10330626.html #gesundheitsdaten
BfArM-Chef über Pläne für Forschungsdateninfrastruktur, Real World Data und mehr

Bald sollen verschiedene Daten gesetzlich Versicherter zu Forschungszwecken zur Verfügung stehen. Das BfArM freut sich und baut dafür die Infrastruktur auf.

heise online
Am Mittwoch den 9.10.2024 ist wieder #bvmiTalk: „Möglichkeiten und Herausforderungen für #medizinischeForschung mit #RealWorldData“ von 17:00-17:45 Uhr. Mit Frau Johanna Apfel-Starke. Anmelden wie immer bei [email protected] #bvmiTalk. #MHH

📣 New paper: Using the present on admission (POA) indicator we explored acute #kidney injuries and sex #disparities It's an explorative analysis showing how the POA flag can help to analyse #routinedata more deeply. #realworlddata #openaccess

@nursingresearch

https://bmjpublichealth.bmj.com/content/2/1/e000131

Acute kidney injury, the present on admission (POA) indicator and sex disparities: observational study of inpatient real-world data in a Swiss tertiary healthcare system. Explorative analysis

Background Regarding kidney disease (KD), sex differences in epidemiology and clinical relevance have been reported. Related to absolute and relative changes of baseline creatinine, different criteria for staging may induce underdiagnosis or overdiagnosis related to sex. At the largest Swiss provider of inpatient acute healthcare, a clinic decision support algorithm ensures exact staging of KD (2012 KDIGO Kidney Disease Improving Global Outcomes Clinical Practice Guideline). Coding of the indicator ‘Present On Admission’ (POA) was introduced at this institution in 2018 to flag postadmission conditions.ObjectiveThe explorative analysis aimed at differences in diagnosis groups. Defined indicators and the distribution of stages in acute kidney injury (AKI) were analysed using the POA flag. Sex differences were reported.MethodsRetrospective observational study. Explorative analysis. Routinely collected health data, 2019 and 2020 (121 757 cases) on the patient history and intensive care treatment duration, comorbidity levels, coded diagnoses, age and sex.Software and statistic: program R, V.4.1.1, SD; median, IQR; prop.test; standardised mean difference.ResultsThe reporting of postadmission diagnoses showed more interhospital transfers, more intensive care stays, higher scores of severity and treatment intensity, more often mechanical ventilation, a higher age, a higher number of diagnoses, a higher complexity level of the related cases and mortality. This observation could be made to a lesser degree for the female population. However, for the female population mortality was higher (stage III AKI 41.6%).ConclusionUsing the POA flag, the results reflect the clinical situation of complications and comorbidities evolving unexpectedly. As our results show sex differences, that is, a lower morbidity of female patients for each stage, but a higher mortality, a deeper evaluation of the implied sex differences in staging of KD should follow.The general results confirm the necessity of a diagnosis-onset reporting in health statistics.

BMJ Public Health

A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures.

https://sciencebusiness.technewslit.com/?p=45455

#News #Press #Science #Business #Epilepsy #Seizures #Neuroscience #Wearable #SmartWatch #Algorithm #MachineLearning #ArtificialIntelligence #Forecast #RealWorldData

A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs.

https://sciencebusiness.technewslit.com/?p=45310

#News #Press #Science #Business #Biologics #Biosimilars #Pharmaceuticals #FDA #Regulations #Grant #RealWorldData #HealthRecords #InsuranceClaims #ManagedCare #DataScience

FDA Funds Study of Real World Data for Biosimilars

A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs.

Science and Enterprise